ClinicalTrials.gg
RecruitingNCT06641297Updated Feb 20, 2026

White Matter Plasticity in Schizophrenia

An interventional study of Music video game in Schizophrenia Disorders, sponsored by University of Maryland, Baltimore. Recruiting at 2 sites in United States. Open to participants aged 15 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
15 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 63 studies in Schizophrenia by University of Maryland, Baltimore — 3 open to participants now, 4 under way, none of them phase 3. Schizophrenia · University of Maryland, Baltimore.

Planned enrollment
27th of 54
36 · median 36
Started
2025
with 1 other
No phase
32 of 63
2 open now
Registered
62nd of 63
by date

Among the 63 studies in Schizophrenia by University of Maryland, Baltimore, this one is the 27th largest by planned enrollment of the 54 interventional ones that give a count, is one of 2 that started in 2025, is one of 32 with no phase, and was the 62nd registered.

Schizophrenia

3,574 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.

Browse Schizophrenia studies →

Open to participants now

3 of the 63 studies in Schizophrenia by University of Maryland, Baltimore are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.

This study: 15 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Schizophrenia by University of Maryland, Baltimore, or all of them as a file.
02

Study summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

03

Conditions studied

  • Schizophrenia Disorders

Browse trials for

Keywords

  • music
  • training
  • plasticity
04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis NOS
  • age 15-45
  • able to provide

Exclusion criteria

Exclusion Criteria:

  • to MRI (metal implants, claustrophobia)
  • medical condition that limits use of hands (ie, arthritis)
  • Active or recent (within 6 months) substance use disorder other than nicotine
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Active training

    Training sessions involving playing the video game 'Guitar Hero'

    Behavioral: Music video game

  • Placebo comparator
    Observation training

    Behavioral: Music video game

Interventions

  • BehavioralMusic video game

    The video game \'Guitar Hero\' will be used as the platform for training for participants to acquire a new \'skill\'

06

What researchers measure

Primary outcomes

  1. White matter microstructure

    fractional anisotropy of white matter tracts as assessed with diffusion tensor imaging

    Time frame: 3 weeks

Secondary outcomes

  1. Brain level of N-acetylaspartate

    NAA levels in motor cortex of brain as measured with magnetic resonance spectroscopy

    Time frame: 3 weeks

07

Study locations

1 of 2 sites recruiting
  • Maryland Psychiatric Research Center
    Catonsville, Maryland 21228, United States
    Recruiting
  • University of Maryland Baltimore - Maryland Psychiatric Research Center
    Catonsville, Maryland 21228, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 763 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's planned 23 months is below that.

Counting every sponsor, half of 776 studies reached it within 32 months; a quarter within 16 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 11, 2024
First posted
Oct 15, 2024
StartActual
Jan 2, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Feb 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06641297
Responsible party
Sponsor
First posted
Oct 15, 2024
Start date
Jan 2, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 20, 2026

Study contacts

Joshua J Chiappelli, MD
Contact
jchiappe@som.umaryland.edu
4104026827

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion